Logo | Name | Σ | ||
---|---|---|---|---|
Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: Pharmaceutical | 3476 | 2593 | 833 | |
Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 627 | 379 | 382 | |
Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 448 | 254 | 261 | |
Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: Biotechnology French Cluster Public business cluster | 313 | 124 | 205 | |
Sifted The leading media brand empowering startup Europe | Backed by the Financial Times. Sifted is the critical friend of the European startup ecosystem – providing startup founders, senior management teams, investors and service providers with the curated insights, in-depth analysis and networking opportunities they need to grow their business. Whatever your role is within the ecosystem, however you like to stay up to speed, we've got something for you: 🗞️ Sifted Daily: Our daily newsletter is the essential morning read for founders, investors and corporates who want a quick digest of the news that matters 🔎 Sifted Pro: Our premium … | 2476 | 1674 | 1008 | |
Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: Biotechnology | 314 | 161 | 160 | |
Eurasanté Accélérateur des innovations santé-nutrition, bien vieillir en région Hauts-de-France Eurasanté is a regional economic development agency specialized in the the health sector. It supports the different actors dedicated to health related activities with their research, creation and development projects. The Biology, Nutrition and Health Sector of the Nord-Pas-De-Calais represents 800 companies, and 22 000 employees. Located at the heart of a business park of over 300 hectares gathering 7 hospitals, 50 research laboratories, 145 companies, 4 universities, 5 specialized training institutes, it constitutes a unique business environment in the largest university-hospital campus over Europe. 3 kinds of services are part … Sectors: Biotechnology Startup accelerator & VC | 494 | 282 | 260 | |
Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: Biotechnology Pharmaceutical | 1561 | 1421 | 60 | |
Atlanpole [Automatic translation follows] By your side to innovate! Technopole of the economic and university basin of Nantes Atlantique, equipped with a European Center of Enterprises and Innovation, carrier of the regional Incubator of Pays de la Loire, pilot and/or partner of several competitiveness clusters. Atlanpole is at the service of: • Innovative project leaders (industrialists, researchers, academics, students, private individuals, etc.) • Innovative companies and laboratories • Actors in economic, scientific and technological development Atlanpole's scope of action is broad and concerns many sectors of activity: • Biotechnologies / Health • ICT / Electronics / IT • Environment / New … | 518 | 256 | 288 | |
Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 598 | 332 | 75 | |
Oxford University Innovation Building a world-leading innovation ecosystem with Oxford University at its heart. Oxford University Innovation Limited is wholly owned by the University of Oxford. The company mission is to be the leading international technology transfer organisation, to transfer technology and expertise from the University of Oxford, to deliver value to all our clients, and to maximise social and economic benefits in a commercial manner. Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Our role is to help University staff and students bring the benefits of their research and expertise to … Sectors: Research | 186 | 76 | 79 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1758 | 1563 | 123 | |
MyData Global We empower individuals by improving digital human rights and the right to self-determination regarding personal data MyData is a human-centred approach to personal data management that combines industry need to data with digital human rights. The purpose is to empower individuals by improving digital human rights and the right to self-determination regarding personal data MyData, Personal data, data ethics, data governance, data sharing, dataspaces, data intermediaries, data protection, privacy, and digital transformation | 283 | 118 | 180 | |
Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: Biotechnology Pharmaceutical | 702 | 551 | 84 | |
Invest in Bavaria - The Business Promotion Agency of the State of Bavaria Supporting site selection & foreign direct investments in Bavaria: We help you finding the ideal location – contact us! Digitalization & Bavaria – two closely interlinked terms. Profit from Bavaria’s boundless opportunities – we help companies from abroad during all processes: From location search to getting access to relevant partners and networks for your business! Who we are & what we offer: Invest in Bavaria has been in existence since 1999. We are the globally working business promotion agency of the State of Bavaria. We focus on a wealth of services regarding your company’s settlement in Bavaria: From the planning … Sectors: Startup accelerator & VC | 130 | 31 | 100 | |
EIT - European Institute of Innovation and Technology EIT - making innovation happen! The EIT was created to drive Europe’s ability to innovate. The EIT is a unique EU initiative, the only one to fully integrate business, education and research. The Institute supports the development of dynamic pan-European partnerships among leading universities, research labs and companies. These are called Innovation Communities and each is dedicated to finding solutions to a specific global challenge. Together with their leading partners, they offer a wide range of innovation and entrepreneurship activities. This includes education courses that combine technical and entrepreneurial skills, business creation and acceleration services and innovation driven research projects. … Sectors: European Union | 584 | 487 | 68 | |
Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1615 | 939 | 333 | |
Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: Biotechnology Pharmaceutical | 1484 | 867 | 336 | |
Boston Consulting Group (BCG) Unlocking the potential of those who advance the world Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we work closely with clients to embrace a transformational approach aimed at benefiting all stakeholders—empowering organizations to grow, build sustainable competitive advantage, and drive positive societal impact. Our diverse, global teams bring deep industry and functional expertise and a range of perspectives that question the status quo and spark change. BCG delivers solutions through leading-edge management … Sectors: Consulting | 2809 | 2324 | 320 | |
Nasdaq At Nasdaq, our purpose is to advance economic progress for all. At Nasdaq, our purpose is to advance economic progress for all. We power stronger economies, create more equitable opportunities, and contribute to a more sustainable world to help our communities, clients, employees, and people of all backgrounds reach their full potential. Meet the #NasdaqFam and learn about our purpose, culture and careers here: https://www.nasdaq.com/about/careers Technology Solutions, Financial Markets, Global Trading, Equities, Market Technology, Market Services, Fixed Income, Derivatives, Corporate Solutions, Global Index Services, Listing Services, and Nasdaq MarketSite Sectors: Finance | 6650 | 4962 | 1162 | |
Eurofins Scientifique With ca. 62,000 staff across 62 countries, Eurofins provides testing, inspection, and certification services. Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. … Tags: CAC40 Sectors: Biotechnology | 257 | 185 | 40 | |
Dia & Co The Challenge: 67% of American women wear sizes 14+—that’s 100 million women. Yet this majority is systematically underserved by the retail industry. The plus size community faces paltry options, unwelcoming environments, and a lack of representation—all adding up to a disappointing experience with style. Our Vision: Style freedom through a life well-lived The Dia & Co Solution: Dia & Co is the only retail service dedicated to meeting the plus size community’s full range of style needs. We’re applying the best of data and technology to serve women who have been ignored for far too long—from developing the shopping experiences … Sectors: Semiconductors | 2164 | 1698 | 335 | |
MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2106 | 1855 | 189 | |
EY EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. Find out more about the EY global network http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, Professional Services, Law, Technology, Consulting, Data, Transformation, Strategy, … Sectors: Consulting, audit | 5450 | 4033 | 1049 | |
Eurostat High quality statistics and data on Europe. Lawful good. EUROSTAT is the statistical office of the European Union. Our mission is to provide high quality statistics and data on Europe. Our values: Show respect for our staff, partners and users Strive for excellence in everything we do Drive innovation in official statistics Promote service orientation Uphold professional independence ESS partnership Eurostat produces European statistics in partnership with National Statistical Institutes and other national authorities in the EU Member States. This partnership is known as the European Statistical System (ESS). It also includes the statistical authorities of the European Economic Area … Sectors: European Union | 10345 | 7424 | 1325 | |
Daiichi Sankyo Passion for Innovation. Compassion for Patients. Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com. Please see below for global employment opportunities: Daiichi Sankyo … Sectors: Pharmaceutical | 17 | 12 | 1 | |
HTGF | High-Tech Gründerfonds Seed Investor. We invest in People. Venture Capital for High-Tech Founders. Made in Germany. HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more … | 888 | 459 | 506 | |
Bayer Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by … Tags: DAX30 Sectors: Chemistry Pharmaceutical | 4729 | 2893 | 637 | |
Fraunhofer-Gesellschaft [Automatic translation follows] Applied research for 75 years. Technology, innovation, added value. The Fraunhofer Society, based in Germany, is the world's leading organization for application-oriented research. With its focus on key technologies relevant to the future and on the utilization of the results in business and industry, it plays a central role in the innovation process. As a guide and source of inspiration for innovative developments and scientific excellence, it helps shape our society and our future. The organization, founded in 1949, currently operates 75 institutes and research facilities in Germany. Around 29,000 employees, mostly with a background in natural … Sectors: Research | 971 | 717 | 256 | |
Plug and Play Tech Center Driving the future forward with corporations, governments, startups, investors, and universities. Plug and Play is the ultimate innovation platform. Our mission is to build the world’s leading innovation platform and make innovation open to anyone, anywhere. We do this by connecting entrepreneurs, corporations, and investors worldwide. Over the past 15 years, we have brought together 35,000+ startups, 500+ world-leading corporations, and hundreds of venture capital firms, universities, and government agencies across 20+ industries. We are active in 50+ locations globally, including the U.S., China, France, Germany, South Africa, Singapore, Indonesia, Brazil, and more. Together with our partners, we are creating … Sectors: Startup accelerator & VC | 3550 | 1986 | 646 |